Accelerate Your Clinical Trials in
Japan & Asia
Meet 3H Medi Solution— Japan’s leader in patient-centric recruitment and In-Home clinical trials. Backed by the M3 Group ecosystem and with access to 2M+ patient database including deep EHR/PHR insights, and Over 90 projects executed for In-home clinical trials in the last four years. Let’s accelerate your clinical trials in Japan — the right patients, at the right time.
20+
Years Experience
Top 50
Global Pharma Clients
90+
Decentralized Trials
2M+
Patient Database
Bridging the Gap to Patients in Asia
We combine digital precision with human touch to deliver recruitment and retention solutions that work.
Japan’s Largest Patient Media Platform & PAG Network
Unlock access to previously untapped patient populations through our proprietary patient engagement ecosystem. 3H Medi Solution owns and operates Japan’s leading clinical trial media platforms, including Seikatsu Kojo WEB, Oncolo, Rare’S, and other group platforms, reaching 11M+ monthly page views.
Why sponsors and CROs trust us:
- Unmatched scale in Oncology & Rare Disease: Through our databases and media platforms, we connect with 220+ Patient Advocacy Groups (PAGs) nationwide.
- Precision patient targeting: Powered by the M3 Group physician-referral network with access to 700K+ physicians, combined with direct-to-patient digital outreach.
- Proven recruitment performance: Supporting 100+ clinical trials every year and contributing to 10,000+ patient randomizations annually.
Reach the right patients, faster — with confidence, compliance, and scale across Japan.
In-Home Clinical Trials (DCT)
Compliant. Scalable. Nationwide.
We bring clinical trials directly to the patient. Through our proprietary “Uchiken” home-nursing network, 3H Medi Solution delivers seamless, GCP-compliant in-home trial execution across Japan — from Hokkaido to Okinawa.
Why sponsors trust our DCT model:
- Unmatched decentralized trial experience: 90+ DCTs completed, supporting 700+ in-home patient visits.
- Nationwide site readiness: 225+ sites onboarded and trained on 3H’s DCT home-nursing model — ready to activate quickly across Japan.
- Scalable, qualified nursing network: 280+ GCP-qualified home-care nurses within the Uchiken network, supported by trusted regional partners for rapid ramp-up and backup coverage.
- End-to-end clinical care: From IV and subcutaneous drug administration to sample collection and vital sign monitoring.
- Logistics & patient safety, built in: Robust SOPs covering nurse-coordinated courier pickup and direct hand-carry of investigational products, ensuring compliance and chain-of-custody integrity.
Decentralized trials in Japan — executed with confidence, consistency, and national reach.
Proven Expertise Where It Matters
Oncology Leadership
A trusted partner in oncology recruitment, supporting 90+ oncology trials with deep expertise across NSCLC, gastric cancer, and rare oncology indications. Trusted by the top 40 global pharmaceutical companies, with 100% utilization across leading sponsors.
Rare Disease Focus
Powered by our proprietary RareS platform and close collaboration with 220+ Patient Advocacy Groups, we excel at finding the needle in the haystack — identifying and engaging rare disease patients with precision and care.
Pan-Asian Reach
Beyond Japan, we deliver coordinated patient recruitment across South Korea, Taiwan, China, and India, combining local execution with consistent quality, compliance, and speed across Asia.
Ready to accelerate your study in Japan?
Don't leave your Asian strategy to chance. Partner with the experts who know the patient landscape best.
Meet us at SCOPE 2026 Orlando
3H Medi Solution Inc. | An M3 Group Company